WESTBOROUGH, Mass., Sept. 8, 2025 /PRNewswire/ -- Echosens, the leader in non-invasive liver diagnostics, is announcing today that the U.S. Food and Drug Administration's (FDA's) Center for Drug ...
The panel, taking place Tuesday, Oct. 13, from 10:15–11:30 a.m. MST during the Self-Insurance Institute of America (SIIA) ...
A FibroScan is a non-invasive test that can help doctors assess the health of the liver without a biopsy. It measures liver stiffness, which can indicate the presence and severity of liver fibrosis, ...
PARIS & WALTHAM, Mass.--(BUSINESS WIRE)--Echosens, a high-technology company offering the FibroScan ® family of products, is pleased to announce its strong presence at the upcoming American ...
The National Institute for Health and Health and Care Excellence (NICE) has recommended FibroScan, a non-invasive hepatic ultrasound scan, as an option for assessing liver damage from fibrosis and ...
BALTIMORE (KFSN) -- Thirty million Americans, or one in 10, have some form of liver disease. It could be scarring from a hepatitis C infection, cirrhosis or even liver cancer. Doctors are now using a ...
PARIS--(BUSINESS WIRE)--Echosens, a high-technology company offering the FibroScan family of products, announces the launch of FibroScan 630 Expert, a high-performance elastography engine that ...